Compounds > 1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine
Page last updated: 2024-09-05

1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine and talabostat

1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine has been researched along with talabostat in 1 studies

Compound Research Comparison

Studies
(1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine)		Trials
(1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine)		Recent Studies (post-2010)
(1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine)		Studies
(talabostat)		Trials
(talabostat)		Recent Studies (post-2010) (talabostat)
140333417

Protein Interaction Comparison

ProteinTaxonomy1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine (IC50)talabostat (IC50)
Kynurenine 3-monooxygenaseRattus norvegicus (Norway rat)0.066
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)0.98
Dipeptidyl peptidase 4Homo sapiens (human)0.1666
Prolyl endopeptidaseHomo sapiens (human)1.8476
Prolyl endopeptidase FAPMus musculus (house mouse)0.0673
Prolyl endopeptidase FAPHomo sapiens (human)0.0792
Dipeptidyl peptidase 8Homo sapiens (human)0.0113
Dipeptidyl peptidase 9Homo sapiens (human)2.2681
Dipeptidyl peptidase 2Homo sapiens (human)0.0437

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Adil Shareef, M; Das, BC; Das, S; Das, Y; Nandwana, NK; Saito, M; Weiss, LM1

Reviews

1 review(s) available for 1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine and talabostat

ArticleYear
Boron-Containing heterocycles as promising pharmacological agents.
    Bioorganic & medicinal chemistry, 2022, 06-01, Volume: 63

    Topics: Boron; Bortezomib; Chemistry, Pharmaceutical

2022